Real-World Treatment Patterns and Clinical Outcomes in Patients With Multiple Myeloma Previously Treated With Lenalidomide and an Anti-CD38 Monoclonal Antibody

There is no uniform standard of care for patients with RRMM with prior exposure to lenalidomide and anti-CD38 mAbs. Survival outcomes are poor, with a need for effective treatments for these patients.

Authors

Institutions

Publication Details

Journal
Clinical Lymphoma Myeloma & Leukemia
Published
2024-12-07
DOI
https://doi.org/10.1016/j.clml.2024.12.002
Citations
8
Primary Topic
Multiple Myeloma Research and Treatments
Type
article
Field-Weighted Citation Impact
3.64

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Real-World Treatment Patterns and Clinical Outcomes in Patients With Multiple Myeloma Previously Treated With Lenalidomide and an Anti-CD38 Monoclonal Antibody

Edward Yu, Susan Fish, Amol D. Dhamane, Brian G.M. Durie et al.
8 citations
Clinical Lymphoma Myeloma & Leukemia
Multiple Myeloma Research and Treatments
3.64
article

Real-World Treatment Patterns and Clinical Outcomes in Patients With Multiple Myeloma Previously Treated With Lenalidomide and an Anti-CD38 Monoclonal Antibody

Edward Yu, Susan Fish, Amol D. Dhamane, Brian G.M. Durie, Ravi Vij, Sundar Jagannath, David F Cella, Robert M. Rifkin, Sikander Ailawadhi, Rafat Abonour, Hans Chulhee Lee, Karthik Ramasamy, Carrie Ho, Sujith Dhanasiri, Liang Liu, Tao Gu, Andrew J. Cowan, David J. Kuter, Thomas S. Marshall, Jiaqi Fang, Jessica Katz, Amir Samuel
article en
8 citations

Abstract

There is no uniform standard of care for patients with RRMM with prior exposure to lenalidomide and anti-CD38 mAbs. Survival outcomes are poor, with a need for effective treatments for these patients.

Clinical Lymphoma Myeloma & LeukemiaVol. 25(5)
Cedars-Sinai Medical Center (US), The University of Texas MD Anderson Cancer Center (US), Harvard University (US), Washington University in St. Louis (US), Oxford Health NHS Foundation Trust (GB), Massachusetts General Hospital (US), Fred Hutch Cancer Center (US), Bristol-Myers Squibb (United States) (US), Rocky Mountain Cancer Centers (US), Mayo Clinic in Florida (US), Oxford University Hospitals NHS Trust (GB), Robert H. Lurie Comprehensive Cancer Center of Northwestern University, Indiana University School of Medicine, Bristol-Myers Squibb (Switzerland) (CH), Indiana University – Purdue University Indianapolis (US), Icahn School of Medicine at Mount Sinai (US)
Bristol-Myers Squibb
Good health and well-being
Openalex Percentile: Top 6%
Multiple Myeloma Research and Treatments
3.64
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.